NOTE 12. STOCKHOLDERS’ EQUITY (DEFICIT)

On March 29, 2019, we issued an aggregate of 70,200 restricted shares of our common stock valued at $112,320, to Messrs. Mark Lipparelli, Norm DesRosiers, Bryan Waters and William Zender who are members of our Board, in consideration of their service on the Board during the three months ended March 31, 2019. These shares vested immediately on the grant date.

On June 28, 2019, we issued an aggregate of 76,400 restricted shares of our common stock valued at $124,532, to Messrs. Mark Lipparelli, Norm DesRosiers, Gavin Isaacs, Bryan Waters and William Zender who are members of our Board, in consideration of their service on the Board during the three months ended June 30, 2019. These shares vested immediately on the grant date.

On May 6, 2019, we redeemed all 23,271,667 shares of our common stock held by Triangulum.

On April 24, 2018, our Board authorized the repurchase of shares of our common stock in an amount not to exceed $1.0 million. Such repurchases may be made from time to time based on market conditions and may be completed in the open market or in privately negotiated transactions. Repurchase transactions will be executed only when we believe that we will remain in compliance with the covenants of the Credit Agreement. Finally, execution of share repurchases may require regulatory approval in one or more jurisdictions. Except for the redemption from Triangulum described above, we have not repurchased any of our common stock as of June 30, 2019.